Table 2.
Cox univariate analysis for 3-year survival in 103 patients
|
3-Year overall survival |
|
3-Year disease-free survival |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
| Hemoglobin (non-anemic vs anemic) |
1.941 |
1.177-3.202 |
0.009 |
1.999 |
1.232-3.244 |
0.005 |
| Tumor location (C vs U vs M vs L) |
0.936 |
0.720-1.218 |
0.623 |
0.883 |
0.686-1.136 |
0.333 |
| Treatment modality (RT vs S + RT vs CRT vs S + CRT) |
0.795 |
0.615-1.027 |
0.079 |
0.874 |
0.697-1.096 |
0.244 |
| TNM stage (I vs II vs III vs IV) |
1.767 |
1.240-2.519 |
0.002 |
2.052 |
1.431-2.945 |
0.000 |
| T stage (T1 vs T2 vs T3 vs T4) |
1.409 |
1.017-1.952 |
0.039 |
1.543 |
1.125-2.116 |
0.007 |
| Status of lymph node (negative vs positive) | 2.676 | 1.582-4.527 | 0.000 | 2.241 | 1.376-3.652 | 0.001 |
C, cervical; CRT, chemoradiotherapy; HR, hazard ratio; L, low; M, middle; RT, radiotherapy; S, surgery; U, upper.